GBA's "2021 Stock Phantasma"

How does the 10-year treasury affect your every day life? Much too much has been made of this. Look at a chart- rates are going up deal with it. They go down they go up.

When stock sell off because they are in a mania or bubble it's much easier to say oh the yeied on the 10 year moves too fast. Rather than we pushed too hard and should of told you to pare back.

My lawd... I remember 14% mortgages! Wake me up when we are at 2.7%.... in like 3 years.
 
You have to watch this one carefully. 1st off No Masks! WTF.
Jan 14th date.... So we are in the Covid...


Right at the 3 or 5 second mark... You are like oh man not the doorman! But wait look carefully at who is being escorted in the building by the young ad executive--- Yes! Inclusive as heck!

1:48 Black couple checking in no problem... White guy smiling

Timeshares! <---Van when we travel again... I want to be part of this Hilton Grand Vibe.
 
One stock that fits that bill is Red Rock Resorts (RRR), which saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 88 to 91. The stock has been on a steady uptrend since July 2020. Gaming and casino resorts, such as Red Rock Resort, should do well as more Americans get vaccinated and return to normalcy.
 
We have an 80% gain still in our little Pot play thank god. Now I'm depressed I went and looked at my etrade account I haven't been there in a few weeks. Jesus.

Terra Tech Corp. Executes Agreement to Acquire Unrivaled
9:15 AM ET 3/3/21 | GlobeNewswire

Terra Tech Corp. Executes Agreement to Acquire Unrivaled

Transaction Brings Vertical Integration, Geographic Expansion to One of the Largest Cannabis Distribution Networks on the West Coast

IRVINE, Calif., March 03, 2021 (GLOBE NEWSWIRE) --Terra Tech Corp. (OTCQX:TRTC) ("Terra Tech" or the "Company") today announced that the Company has executed an agreement to acquire UMBRLA, Inc., which has recently rebranded as Unrivaled ("Unrivaled"), subject to certain closing conditions as set forth in the Company's Current Report on Form 8-K filed this morning, in an all-stock transaction.

Unrivaled is a swiftly growing and well-run diversified cannabis company comprised of several highly recognized cannabis brands complemented by distribution, manufacturing and dispensary operations. Unrivaled brands include Korova, a top ten cannabis brand in California, among a strong portfolio across categories and price points. Unrivaled operates manufacturing and distribution operations in both California and Oregon and dispensaries in California.

Unrivaled owns and manages one of the largest distribution networks on the west coast with over 700 in-network dispensaries throughout Oregon and California, into which Unrivaled sells both its own brands and third-party brands across all major categories: flower products, vape cartridges, extracts, and edibles.

Through licensing agreements, select Unrivaled brands are also sold in over 200 dispensaries throughout Arizona and Oklahoma. Following the merger, Terra Tech expects to continue its licensing expansion of the Korova brand and integrate the Unrivaled portfolio into its existing operations in California and Nevada.

Terra Tech's CEO, Frank Knuettel II, stated, "We are very pleased to have entered into this mutually beneficial transaction which leads to immediate scale, driven by strong brands and revenue growth. Unrivaled has grown markedly since inception, led by a strong management team, including Dallas Imbimbo, co-founder of KushCo Holdings, Inc. (OTCQX: KSHB) and Unrivaled. We intend to integrate Unrivaled's management team into Terra Tech, whose robust leadership is capable of executing on high revenue growth and additional accretive acquisitions."

Knuettel continued, "Following the restructuring of our balance sheet and bringing in new capital in January, this is the first of our anticipated strategic acquisitions building on the foundation formed by my predecessors. Our short-term goal is to become the premier West Coast and Southwest operator of cannabis assets with a focus on brands and dispensaries. Based on our growth trajectories and new operations coming online during 2021, we believe that the combined companies will generate revenues in excess of $70 million in 2021."
 
Deep research)

Lodging REIT reopening timelines still delayed, Wells Fargo sees in new check
Mar. 05, 2021 7:18 PM ETDiamondRock Hospitality Company (DRH)
  • A look at reopening timelines in nine lodging REITs by Wells Fargo lends some new color to how soon quarterlyrevenues (not to mention cash burn) can get back closer to normal.
  • Analyst Dori Kesten found that 87% of rooms are expected to be open on average this quarter - up 350 basis points from Q4, but still down 115 bps from the February 2021 check.
  • That suggests that some combination of lack of demand and/or inflexible cost structures is stretching out the reopening timeline, Kesten writes.
  • Wells Fargo is on record expecting demand to re-accelerate in late March, with the help of "pent-up demand, health of the consumer balance sheet, favorable weather, slowing new case counts and increases in vaccinations."
  • One key finding from the bank's analysis is that just under 80% of the rooms with 2021 reopening dates are located in four markets - San Francisco, New York City, Chicago and Boston - and the vast majority of deferred reopenings were also located in those markets.
  • The largest percentage of deferred reopenings (relative to portfolio size) since Wells Fargo's January check lands on DiamondRock Hospitality(NYSE:DRH), Park Hotels & Resorts(NYSE:PK), Ryman Hospitality Properties(NYSE:RHP)and Pebblebrook Hotel Trust(NYSE:PEB).
  • As for the largest percentage of rooms expected to be open on average this quarter, that list includes Hersha Hospitality Trust(NYSE:HT), Sunstone Hotel Investors(NYSE:SHO), Host Hotels & Resorts(NASDAQ:HST), RLJ Lodging Trust(NYSE:RLJ)and Xenia Hotels & Resorts(NYSE:XHR).
 
Van I am depressed. I often fall apart this time of year. It's seasonal. Thank god it's not health this time -I'm stressing out. I'm emotional- I just saw my etrade account and cried. I cried the other day watching a series called Unorthadox.. I highly recommend it-great TV but damn Stoney get a grip. If I watched Black Stallion now or the wrong movie my kid would find me in a puddle of tears. I'm Jacked up. It's the 1 year from Covid outbreak problem... it's hitting me hard. How did I make it. Moving a stone grotto and now the septic situation the possibly broken pipe that he guy never came back because the 2 feet of snow... So much drama.

I just read an obit why did I do that! it was nice guy, a bird watcher, a guy who loved to watch birds and he's gone now- Covid and he was born ten years after Me!! Suddenly I'm getting angsty... You Can't catch this now!

This poor guy he's dead. Fuck. I was really hoping it was cancer because I love birds I don't watch them (they don't like tat) I just feed them but I really enjoy and envy their lifestyle. in the country the song birds wake you and it's a little like being alive.

... I'm losing it Van... I've held it together through 600 pages it seems, two threads , three variants, hundreds of actionable and profitable ideas and now what! What's left ...

Besides E Hang Holdings...

I can't travel, I have no shot. My kid is going back to school on he 22nd... just in time for his basketball season to be over... I have to choose a college or he does, that is safe. That is in a non gun state or N Carolina... I've decided that's ok... and about an hrs flight time from NYC... I like this Univ Of Charleston but maybe that's just because I've wanted to visit that city....

I yearn to travel again. All my best memories are travel related.... But lets be real I have this huge Dog.. and he's not into it at all....~si
 
Atossa’s Nasal Spray Candidate Could Yet Join the Fight Against COVID-19

March 1, 2021, 9:55 AM·3 min read

The available vaccines’ questionable effectiveness against mutant strains and the logistic challenges of worldwide distribution, suggest the battle against the pandemic is not over yet.

With these factors in mind, Maxim analyst Jason McCarthy thinks Atossa Therapeutics (ATOS) could yet have a role to play in fighting the coronavirus.

McCarthy’s latest endorsement follows the completion of the Phase 1 study for AT-301, Atossa’s nasal spray drug candidate. The treatment targets recently diagnosed Covid-19 patients whose symptoms aren’t severe enough to require hospitalization. The FDA has yet to approve any Covid-19 therapies to be administered at home.

The double-blinded, randomized, placebo-controlled clinical study consisted of 32 healthy adult participants who, over 14 days, received two different dose levels. Overall, AT-301 was found to be safe and well-tolerated.

Based partially on FDA input, the company is planning an additional pre-clinical study which it hopes to kick off in the current quarter, following which Atossa will apply to move forward with a Phase 2 trial.

The early-stage data, McCarthy says, suggests AT-301 may prevent viral entry into host cells. AT-301 is intended for this purpose by inhibiting the spike protein activation.

The analyst notes that AT-301’s components could be utilized to form in the nasal cavity a protective mucosal barrier, which could get in the way and stop the activation taking place.

Three human cell surface enzymes - ACE2, furin, and TMPRSS2 - perform the activation and therefore SARS-CoV-2 mutations and variants do not affect it.

“It is relatively unlikely that subsequent mutations and novel strains of COVID-19 will modify this activation process, which is essential for SARS-CoV-2 propagation,” the 5-star analyst noted. “As such, AT-301 administration to patients with mild symptoms as well as prophylactic distribution to high-risk individuals like healthcare workers and teachers could play a role, along with continued vaccine distribution, as a path out of the COVID-19 pandemic.”
 
You must log in or register to reply here.
Back
Top